Equity Details
Price & Market Data
Price: $1.12
Daily Change: +$0.0498 / 4.45%
Daily Range: $1.02 - $1.12
Market Cap: $137,397,392
Daily Volume: 1,111,652
Performance Metrics
1 Week: 24.45%
1 Month: 41.46%
3 Months: -17.91%
6 Months: -45.54%
1 Year: 79.45%
YTD: -18.52%
About Rani Therapeutics Holdings, Inc. (RANI)
An in-depth look at Rani Therapeutics Holdings, Inc. (RANI). Current price: 1.12, daily change: +$0.0498 / 4.45%. Market cap: 137,397,392. All key performance indicators for a thorough understanding.
Company Details
Employees: 71
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; RT-116 which is in discovery stage for the treatment of obesity; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The has a collaboration agreement with ProGen Co., Ltd. for the o-development and commercialization of RT-114 to treat obesity. Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California.